These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32813759)

  • 1. PPARG expression in colorectal cancer and its association with staging and clinical evolution.
    Villa ALP; Parra RS; Feitosa MR; Camargo HP; Machado VF; Tirapelli DPDC; Rocha JJRD; Feres O
    Acta Cir Bras; 2020; 35(7):e202000708. PubMed ID: 32813759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
    Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
    Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.
    Zafari V; Hashemzadeh S; Hosseinpour Feizi M; Pouladi N; Rostami Zadeh L; Sakhinia E
    Bosn J Basic Med Sci; 2017 Aug; 17(3):255-261. PubMed ID: 28504924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer.
    Yun SH; Roh MS; Jeong JS; Park JI
    Ann Diagn Pathol; 2018 Apr; 33():11-16. PubMed ID: 29566941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
    Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ
    Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction.
    Mallon PW; Sedwell R; Rogers G; Nolan D; Unemori P; Hoy J; Samaras K; Kelleher A; Emery S; Cooper DA; Carr A;
    J Infect Dis; 2008 Dec; 198(12):1794-803. PubMed ID: 18954260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma.
    Kim HH; Kim YS; Kang YK; Moon JS
    World J Gastroenterol; 2012 Feb; 18(6):557-62. PubMed ID: 22363123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
    Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P
    Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer.
    Kwon KA; Yun J; Oh SY; Seo BG; Lee S; Lee JH; Kim SH; Choi HJ; Roh MS; Kim HJ
    Cancer Res Treat; 2016 Jan; 48(1):198-207. PubMed ID: 26130665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K
    Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
    Moon CM; Kwon JH; Kim JS; Oh SH; Jin Lee K; Park JJ; Pil Hong S; Cheon JH; Kim TI; Kim WH
    Int J Cancer; 2014 Feb; 134(3):519-29. PubMed ID: 23852449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
    Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and significance of the Wip1 proto-oncogene in colorectal cancer.
    Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
    Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.
    Al Obeed OA; Alkhayal KA; Al Sheikh A; Zubaidi AM; Vaali-Mohammed MA; Boushey R; Mckerrow JH; Abdulla MH
    World J Gastroenterol; 2014 Dec; 20(48):18390-6. PubMed ID: 25561807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.